Kiniksa Pharmaceuticals International (KNSA) Change in Inventory (2021 - 2026)

Kiniksa Pharmaceuticals International's Change in Inventory history runs 6 years deep, the most recent figure standing at $18.2 million for Q1 2026.

• Quarterly Change in Inventory rose 524.82% year-over-year to $18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.1 million (up 1080.46% YoY) and the FY2025 annual result came in at $28.5 million, up 699.64% from the prior year.
• Change in Inventory was $18.2 million for Q1 2026 at Kiniksa Pharmaceuticals International, up from $13.5 million in the prior quarter.
• Across five years, Change in Inventory topped out at $26.1 million in Q2 2025 and bottomed at -$6.8 million in Q3 2025.
• A 5-year average of $4.1 million and a median of $1.8 million in 2023 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2022 — Change in Inventory slumped 583.23% — and 2024, when it surged 1322.14%.
• Kiniksa Pharmaceuticals International's Change in Inventory stood at $7.0 million in 2022, then dropped by 20.62% to $5.5 million in 2023, then tumbled by 141.81% to -$2.3 million in 2024, then soared by 682.86% to $13.5 million in 2025, then jumped by 35.17% to $18.2 million in 2026.
• Business Quant data shows KNSA's Change in Inventory at $18.2 million in Q1 2026, $13.5 million in Q4 2025, and -$6.8 million in Q3 2025.